Stephen Christopher Linthwaite's most recent trade in Standard BioTools Inc was a trade of 12,465 Common Stock done at an average price of $3.6 . Disclosure was reported to the exchange on Feb. 22, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.62 per share. | 22 Feb 2022 | 12,465 | 328,473 (0%) | 0% | 3.6 | 45,123 | Common Stock |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 7,813 | 7,813 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 7,813 | 326,334 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 7,722 | 340,938 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 7,722 | 61,779 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 6,882 | 27,528 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 6,882 | 333,216 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.49 per share. | 20 Nov 2021 | 11,287 | 315,224 (0%) | 0% | 4.5 | 50,679 | Common Stock |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2021 | 7,813 | 15,626 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2021 | 7,813 | 311,907 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2021 | 7,722 | 326,511 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2021 | 7,722 | 69,501 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2021 | 6,882 | 34,410 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2021 | 6,882 | 318,789 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.53 per share. | 20 Aug 2021 | 11,287 | 304,094 (0%) | 0% | 6.5 | 73,704 | Common Stock |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 7,813 | 300,777 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 7,813 | 23,439 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 7,722 | 77,223 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 7,722 | 315,381 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 6,882 | 307,659 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 6,882 | 41,292 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 155,000 | 155,000 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 155,000 | 380,498 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.52 per share. | 20 May 2021 | 89,329 | 291,169 (0%) | 0% | 5.5 | 493,096 | Common Stock |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 7,813 | 210,894 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 7,813 | 31,252 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 7,722 | 84,945 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 7,722 | 225,498 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 6,882 | 48,174 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 6,882 | 217,776 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Stephen Christopher Linthwaite | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2021 | 186,667 | 186,667 | - | - | Restricted Stock Units |